Accordingly, the aim of this study is to investigate the expression of leptin and Ob-R in the colorectal mucosa from IBD and non-IBD (control group) subjects, using the same samples in which the GLUT5 expression had previously been analyzed. The gene discussed is SLC2A5; the disease is irritable bowel syndrome.